Condition: Sarcoma Metastatic · Sarcoma, Soft Tissue · Sponsor: Wake Forest University Health Sciences
The purpose of this research study is to see how metformin, when used in combination with standard of care (SOC) treatment for metastatic (cancer that has spread) soft tissue sarcoma can improve patient outcomes.
This description comes directly from the study's public registry record.
Leah Wilson, RN · 980-442-2333 · Leah.J.Wilson@advocatehealth.org
Megan Jagosky, MD · 704-446-1242 · Megan.Jagosky@advocatehealth.org
Always discuss trial participation with your own doctor first.
| Levine Cancer Institute | Charlotte, North Carolina, United States | Recruiting |
| Atrium Health Wake Forest Baptist Comprehensive Cancer Center | Winston-Salem, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07291297